Skip to main content
. 2020 Aug 3;7:38. doi: 10.1186/s40621-020-00265-y

Table 4.

Unadjusted Risk-Related Driving Indicators by Tier 1 Drug Class: Mean (Standard Deviation)

Drug Class (N Taking Drug) Deceleration Ratea p Speeding Rateb p Right/Left turn Ratioc p
Use of Drug: No Yes No Yes No Yes
Antihistamine (396) 5.4 (6.2) 5.7 (7.2) .33 7.6 (16.4) 9.27 (21.8) .07 .93(.13) .95(.14) .01
Anti-infective (295) 5.4 (6.4) 5.5 (5.9) .76 7.8 (17.6) 8.2 (14.5) .73 .93(.13) .94(.13) .89
Anti-neoplastic (111) 5.4 (6.3) 7.7 (17.1) .10 7.7 (17.1) 10.7 (21.1) .07 .94(.13) .95(.14) .42
Autonomic drugs (648) 5.3 (6.0) 6.0 (7.6) .01 7.6 (16.5) 8.8 (19.7) .12 .93(.13) .94(.13) .41
Blood formulation, coag, thrombosis (389) 5.3 (6.3) 6.0 (7.0) .08 7.9 (17.7) 7.2 (13.9) .43 .94(.13) .94(.15) .90
Cardiovascular drugs (2146) 5.5 (6.1) 5.4 (6.5) .69 8.3 (18.6) 7.7 (16.8) .43 .94(.13) .94(.13) .80
CNS agents (2051) 5.2 (6.3) 5.5 (6.4) .23 7.1 (16.0) 8.1 (17.8) .13 .93(.14) .94(.13) .23
Electrolytic, Caloric and Water Balance (1601) 5.8 (7.2) 5.1 (5.6) <.01 8.7 (18.7) 7.1 (16.0) .01 .94(.13) .94(.13) .86
Respiratory Tract Agents (105) 5.4 (6.4) 6.0 (6.2) .34 7.6 (17.2) 9.8 (20.0) .23 .94(.13) .93(.13) .81
Eye Ear Nose and Throat Preparations (718) 5.2 (6.1) 6.0 (7.1) <.01 7.9 (17.0) 7.7 (18.0) .82 .93(.13) .94(.13) .13
Gastrointestinal drugs (944) 5.3 (6.4) 5.6 (6.4) .21 7.6 (16.4) 8.4 (19.0) .25 .93(.13) .94(.13) .20
Hormones and Synthetic Substitutes (1300) 5.1 (6.0) 5.9 (6.8) <.01 7.4 (16.0) 8.4 (18.7) .10 .93(.13) .94(.13) .17
Local anesthetics (23) 5.4 (6.2) 10.0 (17.6) <.01 7.8 (17.2) 11.6 (24.2) .30 .94(.13) .96(.14) .47
Skin and Mucous Membranes (484) 5.3 (6.1) 6.0 (7.6) .03 7.7 (16.9) 8.6 (18.8) .30 .93(.13) .94(.13) .45
Smooth Muscle Relaxants (89) 5.4 (6.4) 5.5 (5.1) .86 7.9 (17.4) 6.8 (13.9) .55 .94(.13) .94(.13) .58
Vitamins (1899) 5.6 (6.7) 5.4 (6.2) .41 8.3 (18.6) 7.6 (16.5) .27 .94(.13) .94(.13) .91
Miscellaneous agents (371) 5.4 (6.5) 5.5 (5.6) .85 7.6 (16.7) 9.5 (20.5) .05 .93(.13) .95(.13) .10

a Number of high deceleration (≥0.35 g) events events per 1000 miles driven

b Number of speeding (> 80 mph) events per 1000 miles driven

c Ratio of right turns to left turns; a higher mean ratio is indicative of possible reluctance to make left turns against oncoming traffic